DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

86.95 -2.68 (-2.99%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $86.95 -2.99%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $87.90
Previous Close $89.63
Daily Range $84.14 - $91.94
52-Week Range $69.33 - $263.81
Market Cap $29.8B
P/E Ratio 50.93
Dividend (Yield) $0.00 (0.0%)
Volume 6,728,833
Average Daily Volume 7,101,118
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary Rss Feed

3 Reasons Valeant Pharmaceuticals Intl. Inc. Was Clobbered in January

Following an 11% tumble in January, can you trust Valeant, which appears to be trading at a bargain-basement price?

No Super Bowl bump for Fitbit. Stock at all-time low

No Super Bowl bump for Fitbit. Stock tanks

In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position

3 Stocks Dragging The Health Care Sector Downward

Lou Simpson Adds to Valeant Stake

Valeant's Share Price Continues to Decline

So, Bill Ackman Makes Some Good Points on the Index Bubble . . .

Whitney Tilson's New Emails to Partners

PDL BioPharma: Even After The Dividend Cut, 50% Further Downside Is Possible

Valeant: Shorts In The Cold

See More VRX News...

VRX's Top Competitors

VRX $86.95 (-2.99%)
Current stock: VRX
JNJ $101.97 (-0.03%)
Current stock: JNJ
NVS $72.62 (-0.77%)
Current stock: NVS
RHHBY $31.14 (-0.35%)
Current stock: RHHBY